Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.78662 | 33 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.78955 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.78411 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.73441 | 35 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.77568 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.85257 | 34 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.83581 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.79506 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.75362 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.77914 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.77847 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.75922 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.77592 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78482 | 35 |